<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:18:33" record="8169" source="Espacenet">
	<entities>
		<entity ref="Patent8169" type="Patent">
			<semanticIdentifier>brcris::a85b1700b32f2660ec6aee41d5f5e9f1</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0600679A</semanticIdentifier>
			<semanticIdentifier>epodoc::BRPI0600679</semanticIdentifier>
			<semanticIdentifier>docdb::BRPI0600679A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR2006PI00679</semanticIdentifier>
			<semanticIdentifier>original::PIPI 0600679-5</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=PI0600679"/>
			<field name="identifier.lattes" value="5269711866444667"/>
			<field name="identifier.espacenet" value="PI0600679"/>
			<field name="kindCode" value="A"/>
			<field name="title.espacenet" value="uso farmacológico de neolignanas, seus derivados e análogos, composição e seu processo de obtenção no tratamento de doenças causadas por micobactérias e micobactérias atìpicas"/>
			<field name="title.lattes" value="Uso de baixas doses de DNA plasmideal no controle da resposta imune e vacina para tratar doenças auto-imunes, inflamatórias e alérgicas e/ou infecciosas. P.I. 0.600.679-5. Titularidade da USP"/>
			<field name="depositDate" value="2006-02-23"/>
			<field name="publicationDate" value="2007-10-30"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANA OLIVIA DE SOUZA"/>
			<field name="inventor" value="CELIO LOPES SILVA"/>
			<field name="inventor" value="LAURO EUCLIDES SOARES BARATA"/>
			<field name="inventor" value="MARIA VITORIA LOPES BADRA BENTLEY"/>
			<field name="inventor" value="PAULO ROBERTO REGAZI MINARINI"/>
			<field name="applicant" value="UNIVERSIDADE DE SAO PAULO - USP"/>
			<field name="applicant" value="UNIVERSIDADE ESTADUAL DE CAMPINAS - UNICAMP"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61K31/09AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="09AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K9/08AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="9"/>
				<field name="subgroup" value="08AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K36/575AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="36"/>
				<field name="subgroup" value="575AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="4"/>
				<field name="text" value="A61P31/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="5"/>
				<field name="text" value="A61P31/04AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="04AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="6"/>
				<field name="text" value="A61P33/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="33"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="7"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="8"/>
				<field name="text" value="C07C41/16AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="41"/>
				<field name="subgroup" value="16AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="9"/>
				<field name="text" value="C07C41/34AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="41"/>
				<field name="subgroup" value="34AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="10"/>
				<field name="text" value="C07C43/02AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="43"/>
				<field name="subgroup" value="02AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="11"/>
				<field name="text" value="C07C43/20AI"/>
				<field name="section" value="C"/>
				<field name="class" value="07"/>
				<field name="subclass" value="C"/>
				<field name="group" value="43"/>
				<field name="subgroup" value="20AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="12"/>
				<field name="text" value="A61K127/00AN"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="127"/>
				<field name="subgroup" value="00AN"/>
			</field>
			<field name="abstract.espacenet" value="Uso farmacológico de neolignanas, seus derivados e análogos, composição e seu processo de obtenção no tratamento de doenças causadas por microbactérias e microbactérias atípicas A presente invenção descreve o potencial uso de compostos da classe de neolignanas na área da saúde, tanto humana como animal, no tratamento de infecções e doenças já estabelecidas (tuberculose humana, tuberculose bovina, hanseníase e microbacterioses, além os casos em que as microbactérias atuam de forma oportunista, como por exemplo na síndrome da imunodeficiência adquirida - HIV), causadas pó microbactérias e microbactérias atípicas, sendo, portanto, aplicável no setor farmacêutico. Mais especificamente, a presente invenção se refere, de forma não limitada, a utilização de micro ou nanopartículas poliméricas dos ácidos lático e glicólico (D,L-PLGA), contendo neolignanas e/ou seus derivados e análogos sintéticos obtidas como por exemplo pela técnica modificada de emulsificação e evaporação de solvente, como um sistema de liberação modificada de fármaco para o tratamento de doenças infecciosas como a tuberculose e tuberculose associada a outras doenças. As formulações são estáveis e adequadas para uso humano ou animal e podem ser administradas por diferentes vias como por exemplo por via oral, nasal, subcutânea, intradérmica, intramuscular ou ainda podem ser associadas a outras formulações."/>
			<field name="originatesFrom" value="38617720"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0600679"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BRPI0600679"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="PI0600679"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR2006PI00679"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value="PI"/>
				<field name="number" value="PI 0600679-5"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person5574" type="Person">
			<semanticIdentifier>lattes::5269711866444667</semanticIdentifier>
			<field name="identifier.lattes" value="5269711866444667"/>
			<field name="name" value="Celio Lopes Silva"/>
		</entity>
		<entity ref="OrgUnit4399" type="OrgUnit">
			<semanticIdentifier>brcris::1c9b85b611db26412014623d307ecadc</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE DE SAO PAULO - USP"/>
		</entity>
		<entity ref="OrgUnit4400" type="OrgUnit">
			<semanticIdentifier>brcris::b3b0da02d9d1e810f13f21692c1f469b</semanticIdentifier>
			<field name="name" value="UNIVERSIDADE ESTADUAL DE CAMPINAS - UNICAMP"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent8169" toEntityRef="Person5574" type="Inventor"/>
		<relation fromEntityRef="Patent8169" toEntityRef="OrgUnit4399" type="Applicant"/>
		<relation fromEntityRef="Patent8169" toEntityRef="OrgUnit4400" type="Applicant"/>
	</relations>
</entity-relation-data>
